ADCT · ADC Therapeutics SA · Debt
$1.59
+0.00 (+0.00%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$202.99M
Shares
127.67M
Volume · Oct 27
1.25M
Avg daily vol (3M)
1.55M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of long-term debt | 2026-06-30 | USD 6,180,000 | 10-Q filed 2026-08-13 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 946,000 | 10-Q filed 2026-08-13 |
| Secured debt, including current maturities | 2026-06-30 | USD 116,600,000 | 10-Q filed 2026-08-13 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
18 filings
18 filers
Visit website
Investor relations